Genentech Sues Eli Lilly For Violating Just-Issued Drug Patent
Genentech has sued Eli Lilly for infringing the asserted claims of a just-issued patent through sales of Taltz, a psoriasis drug that has been on the market since 2016, according to...To view the full article, register now.
Already a subscriber? Click here to view full article